VRA
Vera Bradley Inc.
Latest News for VRA
In a report released on April 2, Kambiz Yazdi from BTIG maintained a Buy rating on Zevra Therapeutics, with a price target of $23.00. According to ......
In a report released on April 2, Kambiz Yazdi from BTIG maintained a Buy rating on Zevra Therapeutics, with a price target of $23.00. According to ......
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Savara (SVRA) and Edwards Lifesciences (EW) with bul......
LifeSci Capital analyst Francois Brisebois maintained a Buy rating on Savara today and set a price target of $11.00. According to TipRanks, Brisebo......
Which stocks are best to buy now? According to Top Wall Street Analysts, the three stocks listed below are Strong Buys. Each stock received a new B......
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Savara (SVRA – Research Report), Erasca (ERAS – Rese......
Vera Bradley ( ($VRA) ) has issued an update. On March 12, 2026, Vera Bradley, Inc. named Ian Bickley as Chief Executive Officer and Chairman of th......
Analysts have been eager to weigh in on the Healthcare sector with new ratings on Zevra Therapeutics (ZVRA – Research Report), Verrica Pharmaceutic......
In a report released today, from Roth MKM maintained a Buy rating on Zevra Therapeutics, with a price target of $21.00. In addition to Roth MKM, Ze......
In a report released today, Francois Brisebois from LifeSci Capital reiterated a Buy rating on Savara, with a price target of $11.00. Brisebois cov......
News data is sourced from MarketXLS API and updated regularly.
Showing 10 of 11 articles.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | VRA | $3.74 | -1.3% | 138.46K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |